183 related articles for article (PubMed ID: 22524707)
1. The fraction dose absorbed, in humans, and high jejunal human permeability relationship.
Dahan A; Lennernäs H; Amidon GL
Mol Pharm; 2012 Jun; 9(6):1847-51. PubMed ID: 22524707
[TBL] [Abstract][Full Text] [Related]
2. High-permeability criterion for BCS classification: segmental/pH dependent permeability considerations.
Dahan A; Miller JM; Hilfinger JM; Yamashita S; Yu LX; Lennernäs H; Amidon GL
Mol Pharm; 2010 Oct; 7(5):1827-34. PubMed ID: 20701326
[TBL] [Abstract][Full Text] [Related]
3. Regional-dependent intestinal permeability and BCS classification: elucidation of pH-related complexity in rats using pseudoephedrine.
Fairstein M; Swissa R; Dahan A
AAPS J; 2013 Apr; 15(2):589-97. PubMed ID: 23440549
[TBL] [Abstract][Full Text] [Related]
4. Translating Human Effective Jejunal Intestinal Permeability to Surface-Dependent Intrinsic Permeability: a Pragmatic Method for a More Mechanistic Prediction of Regional Oral Drug Absorption.
Olivares-Morales A; Lennernäs H; Aarons L; Rostami-Hodjegan A
AAPS J; 2015 Sep; 17(5):1177-92. PubMed ID: 25986421
[TBL] [Abstract][Full Text] [Related]
5. The effect of amiloride on the in vivo effective permeability of amoxicillin in human jejunum: experience from a regional perfusion technique.
Lennernäs H; Knutson L; Knutson T; Hussain A; Lesko L; Salmonson T; Amidon GL
Eur J Pharm Sci; 2002 Apr; 15(3):271-7. PubMed ID: 11923059
[TBL] [Abstract][Full Text] [Related]
6. Intestinal permeability and its relevance for absorption and elimination.
Lennernäs H
Xenobiotica; 2007; 37(10-11):1015-51. PubMed ID: 17968735
[TBL] [Abstract][Full Text] [Related]
7. The complexity of intestinal permeability: Assigning the correct BCS classification through careful data interpretation.
Zur M; Hanson AS; Dahan A
Eur J Pharm Sci; 2014 Sep; 61():11-7. PubMed ID: 24262076
[TBL] [Abstract][Full Text] [Related]
8. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
9. Prediction of human absorption of a trioxane antimalarial drug (CDRI 99/411) using an in-house validated in situ single-pass intestinal perfusion model.
Wahajuddin ; Singh SP; Patel K; Pradhan T; Siddiqui HH; Singh SK
Arzneimittelforschung; 2011; 61(9):532-7. PubMed ID: 22029231
[TBL] [Abstract][Full Text] [Related]
10. The low/high BCS permeability class boundary: physicochemical comparison of metoprolol and labetalol.
Zur M; Gasparini M; Wolk O; Amidon GL; Dahan A
Mol Pharm; 2014 May; 11(5):1707-14. PubMed ID: 24735251
[TBL] [Abstract][Full Text] [Related]
11. MRP2 mediated drug-drug interaction: indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting.
Dahan A; Amidon GL
Int J Pharm; 2010 Feb; 386(1-2):216-20. PubMed ID: 19944137
[TBL] [Abstract][Full Text] [Related]
12. Segmental-dependent membrane permeability along the intestine following oral drug administration: Evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat.
Dahan A; West BT; Amidon GL
Eur J Pharm Sci; 2009 Feb; 36(2-3):320-9. PubMed ID: 19028572
[TBL] [Abstract][Full Text] [Related]
13. Circadian variations in exsorptive transport: in situ intestinal perfusion data and in vivo relevance.
Okyar A; Dressler C; Hanafy A; Baktir G; Lemmer B; Spahn-Langguth H
Chronobiol Int; 2012 May; 29(4):443-53. PubMed ID: 22489638
[TBL] [Abstract][Full Text] [Related]
14. The utility of rat jejunal permeability for biopharmaceutics classification system.
Zakeri-Milani P; Valizadeh H; Tajerzadeh H; Islambulchilar Z
Drug Dev Ind Pharm; 2009 Dec; 35(12):1496-502. PubMed ID: 19929209
[TBL] [Abstract][Full Text] [Related]
15. Significance of peptide transporter 1 in the intestinal permeability of valacyclovir in wild-type and PepT1 knockout mice.
Yang B; Smith DE
Drug Metab Dispos; 2013 Mar; 41(3):608-14. PubMed ID: 23264448
[TBL] [Abstract][Full Text] [Related]
16. Predicting the human jejunal permeability and fraction absorbed of fluoroquinolones based on a biophysical model.
Wang C; Avdeef A; Zhang W; Tam KY
Biomed Mater Eng; 2014; 24(6):3849-54. PubMed ID: 25227102
[TBL] [Abstract][Full Text] [Related]
17. Regional intestinal drug permeation: biopharmaceutics and drug development.
Lennernäs H
Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing regional differences in intestinal absorption of UK-343,664 in rat: possible role in dose-dependent pharmacokinetics.
Kaddoumi A; Fleisher D; Heimbach T; Li LY; Cole S
J Pharm Sci; 2006 Feb; 95(2):435-45. PubMed ID: 16381015
[TBL] [Abstract][Full Text] [Related]
19. Intestinal permeability of metformin using single-pass intestinal perfusion in rats.
Song NN; Li QS; Liu CX
World J Gastroenterol; 2006 Jul; 12(25):4064-70. PubMed ID: 16810761
[TBL] [Abstract][Full Text] [Related]
20. The biopharmaceutics of successful controlled release drug product: Segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tract.
Zur M; Cohen N; Agbaria R; Dahan A
Int J Pharm; 2015 Jul; 489(1-2):304-10. PubMed ID: 25957705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
